Opportunistic screening for atrial fibrillation with a single lead device in geriatric patients

Lennaert Ar Zwart, René Wmm Jansen, Jacob H Ruiter, Tjeerd Germans, Suat Simsek, Martin Ew Hemels, Lennaert Ar Zwart, René Wmm Jansen, Jacob H Ruiter, Tjeerd Germans, Suat Simsek, Martin Ew Hemels

Abstract

Objective: To determine the diagnostic yield of repeated screening for atrial fibrillation (AF) among geriatric patients.

Methods: A pragmatic prospective cohort study into applying opportunistic screening for AF with a handheld single lead ECG device (SLD) in a geriatric cohort. Consecutive patients of 65 years old and older visiting the geriatric outpatient clinic were eligible for inclusion. A 12 lead ECG was performed, followed by measurements with the SLD during every visit to the geriatric outpatient clinic. A frailty index was based on the accumulation of deficits model.

Results: 478 patients were eligible. Patients were excluded if they did not give informed consent (17 patients), had a pacemaker or implantable cardioverter defibrillator (20 patients), or had incomplete medical files (two patients). After exclusion, 439 patients participated in this study. The mean age was 78 years (range 65 to 100 years), 54% were female. AF was known in 89 patients (20%), first detected on the baseline ECG in four patients (1%) and first detected with the SLD in 20 patients (5%) during follow up visits. Sensitivity of the SLD was 90.0%, specificity 99.0%, negative predictive value 99.7%, and positive predictive value 73.5%. Most patients (82%) with AF were frail and 53% were severely frail.

Conclusion: Repeated screening in geriatric patients has a five times higher diagnostic yield than usual care. It was easily combined with usual care. Because of the positive predictive value of 73.5%, it remains necessary to confirm AF with a 12 lead ECG or 24-h Holter monitoring.

Keywords: Atrial fibrillation; Frailty; Geriatric patients; Opportunistic screening; The elderly.

Institute of Geriatric Cardiology.

References

    1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–1678.
    1. Dietzel J, Haeusler KG, Endres M. Does atrial fibrillation cause cognitive decline and dementia? Europace. 2018;20:408–419.
    1. Moffitt P, Lane DA, Park H, et al. Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review. Age Ageing. 2016;45:767–775.
    1. Ihara M, Washida K. Linking atrial fibrillation with Alzheimer's disease: epidemiological, and mechanistic evidence. J Alzheimers Dis. 2018;62:61–72.
    1. Bunch TJ, Weiss JP, Crandall BG, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm. 2010;7:433–437.
    1. Heeringa J, van der Kuip DAM, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–953.
    1. Madhavan M, Holmes DN, Piccini JP, et al. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019;211:77–89.
    1. Oqab Z, Pournazari P, Sheldon RS. What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis. J Atr Fibrillation. 2018;10:1870.
    1. Lefebvre MD, St-Onge M, Glazer-Cavanagh M, et al. The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: The FRAIL-AF Study. Can J Cardiol. 2016;32:169–176.
    1. Zwart LAR, Germans T, Simsek S, et al. Atrial fibrillation, anticoagulation, and major bleeding episodes in geriatric patients at the risk of Falling. OBM Geriat. doi: 10.21926/obm.geriatr.1903071. Published online first: Oct 10, 2019.
    1. Olsson and Engdahl. Detection of atrial fibrillation with intermittent handheld electrocardiogram in patients with ischemic stroke and transient ischemic attack. J Stroke and Cerebrovasc Dis. 2016;25:2648–2252.
    1. Sobocinski PD, Rooth EA, Kull VF, et al. Improved screening for silent atrial fibrillation after ischemic stroke. Europace. 2017;14:1112–1116.
    1. Engdahl J, Andersson L, Mirskaya M, et al. Stepwise screening of atrial fibrillation in a 75-year-old population. Implications for stroke prevention. Circulation. 2013;127:930–937.
    1. Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF Study. Thromb Haemost. 2014;111:1167–1176.
    1. Tieleman RG, Plantinga Y, Rinkes D, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace. 2014;16:1291–1295.
    1. Kaasenbrood F, Hollander M, Rutten FH, et al. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination. Europace. 2016;18:1514–1520.
    1. Ramkumar S, Nerlekar N, D'Souza, et al. Atrial fibrillation detection using single lead portable electrocardiographic monitoring: a systematic review and meta-analysis. BMJ Open. 2018;8:e024178.
    1. Vaes B, Stalpaert S, Tavemier K, et al. The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care. BMC Fam Pract. 2014;15:113.
    1. Searle SD, Mitnitski A, Gahbauer EA, et al. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.
    1. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontology. 2007;62A:722–727.
    1. Mitnitski A, Song X, Skoog I, et al. Relative fitness and frailty of elderly men and women in developed countries, in relation to mortality. J Am Geriatr Soc. 2005;53:2184–2189.
    1. Tulner LR, Van Campen JPCM, Kuper IMJA, et al. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation. A prospective, descriptive study. Drugs Aging. 2010;27:39–50.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe